• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Infect Control . SARS-CoV-2 Antigen Rapid Tests and Universal Screening for COVID-19 Omicron Variant among Hospitalised Children

tetano

Editor, Senior Moderator
Am J Infect Control


. 2022 Nov 9;S0196-6553(22)00784-2.
doi: 10.1016/j.ajic.2022.11.002. Online ahead of print.
SARS-CoV-2 Antigen Rapid Tests and Universal Screening for COVID-19 Omicron Variant among Hospitalised Children


Kai-Qian Kam[SUP] 1 [/SUP], Matthias Maiwald[SUP] 2 [/SUP], Chia Yin Chong[SUP] 3 [/SUP], Koh Cheng Thoon[SUP] 3 [/SUP], Karen Donceras Nadua[SUP] 3 [/SUP], Liat Hui Loo[SUP] 4 [/SUP], Yelen[SUP] 5 [/SUP], Natalie Woon Hui Tan[SUP] 3 [/SUP], Jiahui Li[SUP] 3 [/SUP], Chee Fu Yung[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Clinical utility of universal antigen rapid test (ART) in the paediatric setting are unknown. We aimed to assess the performance and utility of universal ART in hospitalised children (≥ 5-year-old) to prevent nosocomial COVID-19 transmission.
Methods: Cross-sectional study involving all hospitalized paediatric patients aged ≥ 5-year-old from 2 periods during Omicron wave. Clinical data, ART and polymerase chain reaction (PCR) test results were collected.
Results: A total of 444 patients were included from the 2 study periods, and 416 patients (93.7%) had concordant results between ART and PCR. The overall sensitivity and specificity of ART were 83.3% (95% CI: 75.2-89.3) and 97.5% (95% CI: 95.0-98.8), respectively. Negative predictive values (NPV) of ART between the Omicron emergence and Omicron peak periods for a probable case group were 71.4% and 66.7%, respectively, and for a suspect case group 91.4% and 75.0%, respectively. NPV for an unlikely case group was >95% in both periods. Positive predictive value of ART was >85% for probable and suspect case groups in both periods. Seventy-five percent of patients (n=15) who were incorrectly classified as SARS-CoV-2 negative by ART had potentially viable virus. No large nosocomial transmission clusters were detected.
Conclusions: Universal ART screening may limit nosocomial outbreaks in hospitalised children. The performance can be optimised by considering clinical symptoms, exposure and periods within COVID waves.

Keywords: COVID-19; Coronavirus disease 2019; Severe Acute Respiratory Syndrome Coronavirus 2; antigen rapid test; children; screening; sensitivity; specificity.
 
Back
Top Bottom